We will quote to you most important and trendy news about all kind of Vaccine of the best health sites Like : "newsobserver" and the most famous medical experts : The Editorial Board
daily : 2016-12-29 & on time : 20:38
referring to
An Ebola vaccine gets beyond the research stage
image uploaded by "newsobserver" site
3:06 What the heck is going on in the NC Legislature?Pause2:58 UNC's Larry Fedora talks recruitment, cowboy hats and the Sun Bowl.6:17 Coach Roy Williams battles sickness and Monmouth3:55 UNC's Jones on his road-tripping family, NFL decisions and Sun Bowl practice2:27 UNC academic scandal explained5:18 Roy Williams on win over Northern Iowa and the NCAA investigation11:06 Cooper on HB2: 'Today, the legislature had the chance to do the right thing for NC and they failed'3:37 President Obama tells Americans to not make Russian hacks "a political football"0:07 NC State's Dennis Smith's monster jam
about the details read more from here
Final trial results confirm Ebola vaccine provides high protection against disease
image uploaded by "who" site
Final trial results confirm Ebola vaccine provides high protection against disease23 December 2016 | GENEVA - An experimental Ebola vaccine was highly protective against the deadly virus in a major trial in Guinea, according to results published today in The Lancet.The vaccine is the first to prevent infection from one of the most lethal known pathogens, and the findings add weight to early trial results published last year.The vaccine, called rVSV-ZEBOV, was studied in a trial involving 11 841 people in Guinea during 2015.
about the details read more from here
The new '100% effective' Ebola vaccine owes a debt to the scientists who beat smallpox
image uploaded by "independent" site
Almost a year after the official end of the Ebola outbreak in west Africa, the final results from one of the only vaccine trials for the virus are now in – and they look very promising.This is the only data we have on a vaccine against Ebola in humans, and it looks very safe and highly effective during an outbreak setting.Writing in the journal The Lancet, an international team led by the World Health Organisation (WHO) has shown the rVSV-ZEBOV vaccine produced by Merck can protect both individuals and a whole population through its trials in Guinea.
about the details read more from here
WHO endorses 'very effective' Ebola vaccine prototype
image uploaded by "aljazeera" site
With major questions still remaining unanswered, WHO says the vaccine tested in Guinea could be registered in 2018.A major trial has shown a prototype vaccine to be "very effective" against the deadly Ebola virus, according to the World Health Organization that co-funded the study.Not one of the 6,000 people in Guinea who were given the test vaccine last year contracted the disease within 10 days, WHO said on Friday announcing the final results, without elaborating on what happens after 10 days as Ebola has an incubation period of up to three weeks.
about the details read more from here
No comments:
Post a Comment